[LGND] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 19.28%
YoY- 205.12%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 56,157 50,464 33,375 27,995 29,267 38,185 21,619 89.07%
PBT 55,312 30,665 12,071 8,300 6,193 7,230 804 1583.30%
Tax 10,033 37,675 3,645 2,242 1,114 10,355 160 1482.34%
NP 45,279 -7,010 8,426 6,058 5,079 -3,125 644 1607.91%
Tax Rate -18.14% -122.86% -30.20% -27.01% -17.99% -143.22% -19.90% -
Total Cost 10,878 57,474 24,949 21,937 24,188 41,310 20,975 -35.47%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 80.63 -13.89 25.25 21.64 17.35 -8.18 2.98 803.08%
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS 2.13 -0.34 0.40 0.29 0.24 -0.15 0.03 1619.09%
EPS Diluted 1.83 -0.33 0.36 0.26 0.22 -0.15 0.03 1453.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.